Market Research Logo

Cardiac Marker Testing Market by Type (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Product (Reagent, Instrument), Method (Chemiluminescence, ELISA), Disease (Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC) - Global Forecast to 2021

Cardiac Marker Testing Market by Type (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Product (Reagent, Instrument), Method (Chemiluminescence, ELISA), Disease (Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC) - Global Forecast to 2021

The global cardiac marker testing market is estimated to grow at a CAGR of 8.8% from 2016 to 2021 to reach USD 3.50 billion by 2021. Factors such as growing incidences of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are fueling the growth of the cardiac marker testing market. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are the key factors limiting the growth of the global cardiac marker testing market.

Based on the type, the troponin I and T type segment is expected to account for the largest share of the global cardiac marker testing market in 2016. The high sensitivity and specificity of troponin I and T in early detection of cardiovascular diseases is stimulating the growth of this type segment. In addition, the long elevation times and rapid prediction of outcomes is also driving the growth of this market.

Geographically, North America commands the largest share of the global cardiac marker testing market in 2016, followed by Europe. The cardiac marker testing market in North America is primarily driven by the increasing incidence of cardiovascular diseases, growing public-private investments, NIH support towards the development of novel cardiac biomarkers, and rising geriatric population.

The global cardiac marker testing market is highly competitive, with a large number of global and local players. As of 2016, the global cardiac marker testing market was dominated by Roche Diagnostics Limited (a subsidiary of F. Hoffman-La Roche Ltd.) (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), bioMérieux SA (France), and Alere Inc. (U.S.). Product launches, approvals, and showcases and partnerships and agreements were the major strategies adopted by market players to achieve growth in the cardiac marker testing market.

Research Coverage
This report studies the cardiac marker testing market based on type, product, disease, and usability. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions

Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the cardiac marker testing market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios and services offered by the major players in the cardiac marker testing market. The report analyzes the cardiac marker testing market based on type, product, disease, and region

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the cardiac marker testing market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cardiac marker testing systems across geographies

• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the cardiac marker testing market

• Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the cardiac marker testing market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH METHODOLOGY STEPS
    • SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • EVOLUTION
    • CURRENT SCENARIO
    • FUTURE OUTLOOK
    • CONCLUSION
  • PREMIUM INSIGHTS
    • GLOBAL CARDIAC MARKER TESTING MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: CARDIAC MARKER TESTING MARKET, BY TECHNOLOGY, 2016
    • CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2016 VS. 2021
    • CARDIAC MARKER TESTING MARKET, BY PRODUCT, 2016 VS. 2021
    • GEOGRAPHICAL SNAPSHOT OF THE CARDIAC MARKER TESTING MARKET, 2016
    • LIFE CYCLE ANALYSIS, BY REGION
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
  • INDUSTRY INSIGHTS
    • INTRODUCTION
    • VALUE CHAIN ANALYSIS
    • INDUSTRY TRENDS
      • ONGOING RESEARCH ON NOVEL CARDIAC BIOMARKERS FOR CARDIOVASCULAR DISEASES
      • COMBINATION OF VARIOUS CARDIAC BIOMARKERS TO IMPROVE PATIENT MANAGEMENT
      • DEVELOPMENT OF HIGH-SENSITIVITY TROPONIN ASSAYS
    • PORTER'S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
  • CARDIAC MARKER TESTING MARKET, BY TYPE
    • INTRODUCTION
      • Table CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
    • TROPONIN I AND T
      • Table CHARACTERISTICS OF TROPONIN CARDIAC MARKER
      • Table CARDIAC MARKER TESTING MARKET SIZE FOR TROPONIN I AND T, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE TROPONIN I AND T, BY COUNTRY, 2014-2021 (USD MILLION)
    • CK-MB
      • Table CHARACTERISTICS OF CK-MB CARDIAC MARKER
      • Table CARDIAC MARKER TESTING MARKET SIZE FOR CK-MB, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE CK-MB, BY COUNTRY, 2014-2021 (USD MILLION)
    • BNP OR NT-PROBNP
      • Table CARDIAC MARKER TESTING MARKET SIZE FOR BNP OR NT-PROBNP, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE BNP OR NT- PROBNP, BY COUNTRY, 2014-2021 (USD MILLION)
    • MYOGLOBIN
      • Table CHARACTERISTICS OF MYOGLOBIN CARDIAC MARKER
      • Table CARDIAC MARKER TESTING MARKET SIZE FOR MYOGLOBIN, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE FOR MYOGLOBIN, BY COUNTRY, 2014-2021 (USD MILLION)
    • HSCRP
      • Table CUT-OFFS FOR CRP USING STANDARDIZED ASSAY
      • Table CARDIAC MARKER TESTING MARKET SIZE FOR HSCRP, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE FOR HSCRP, BY COUNTRY, 2014-2021 (USD MILLION)
    • OTHER BIOMARKERS
      • Table CARDIAC MARKER TESTING MARKET SIZE FOR OTHER BIOMARKERS, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE FOR OTHER BIOMARKERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • CARDIAC MARKER TESTING MARKET, BY PRODUCT
    • INTRODUCTION
      • Table CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
    • REAGENTS AND KITS
      • Table CARDIAC MARKER TESTING REAGENTS AND KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • INSTRUMENTS
      • Table CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
      • CHEMILUMINESCENCE
        • Table CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE FOR CHEMILUMINESCENCE, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE FOR CHEMILUMINESCENCE, BY COUNTRY, 2014-2021 (USD MILLION)
      • IMMUNOFLUORESCENCE
        • Table CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE FOR IMMUNOFLUORESCENCE, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2014-2021 (USD MILLION)
      • ELISA
        • Table CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE FOR ELISA, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE FOR ELISA, BY COUNTRY, 2014-2021 (USD MILLION)
      • IMMUNOCHROMATOGRAPHY
        • Table CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE FOR IMMUNOCHROMATOGRAPHY, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: CARDIAC MARKER TESTING INSTRUMENTS MARKET SIZE FOR IMMUNOCHROMATOGRAPHY, BY COUNTRY, 2014-2021 (USD MILLION)
  • CARDIAC MARKER TESTING MARKET, BY DISEASE
    • INTRODUCTION
      • Table CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
    • MYOCARDIAL INFARCTION
      • Table CARDIAC MARKER TESTING MARKET SIZE FOR MYOCARDIAL INFARCTION, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE FOR MYOCARDIAL INFARCTION, BY COUNTRY, 2014-2021 (USD MILLION)
    • CONGESTIVE HEART FAILURE
      • Table CARDIAC MARKER TESTING MARKET SIZE FOR CONGESTIVE HEART FAILURE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE FOR CONGESTIVE HEART FAILURE, BY COUNTRY, 2014-2021 (USD MILLION)
  • CARDIAC MARKER TESTING MARKET, BY TYPE OF TESTING
    • INTRODUCTION
      • Table CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2014-2021 (USD MILLION)
    • LABORATORY TESTING
      • Table CARDIAC MARKER LABORATORY TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER LABORATORY TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • POINT-OF-CARE TESTING
      • Table CARDIAC MARKER POINT-OF-CARE TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER POINT-OF-CARE TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • CARDIAC MARKER TESTING MARKET, BY REGION
    • INTRODUCTION
      • Table CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2014-2021 (USD MILLION)
      • U.S.
        • Table U.S.: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.S.: CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table U.S.: CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table U.S.: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2014-2021 (USD MILLION)
      • CANADA
        • Table CANADA: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CANADA: CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table CANADA: CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table CANADA: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2014-2021 (USD MILLION)
    • EUROPE
      • RISING INCIDENCE OF CVD
      • INCREASING NUMBER OF CONFERENCES AND SYMPOSIUMS
      • RISING PARTNERSHIPS AND COLLABORATIONS FOR THE DEVELOPMENT OF CARDIAC BIOMARKERS
      • INCREASING GOVERNMENT INVESTMENTS TO DEVELOP NOVEL CARDIAC BIOMARKERS
        • Table EUROPE: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table EUROPE: CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table EUROPE: CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table EUROPE: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2014-2021 (USD MILLION)
    • ASIA-PACIFIC
      • INCREASING INCIDENCE OF CVD
      • INCREASING AWARENESS DUE TO GOING CONFERENCES AND INITIATIVES TAKEN BY MARKET PLAYERS
      • GOVERNMENT INVESTMENTS TOWARDS CARDIAC BIOMARKER RESEARCH
        • Table ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
        • Table ASIA-PACIFIC: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2014-2021 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table ROW: CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
      • Table ROW: CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • STRATEGIC OVERVIEW
    • LEADING PLAYERS IN THE CARDIAC MARKER TESTING MARKET
    • COMPETITIVE SITUATION AND TRENDS
      • PRODUCT LAUNCHES, APPROVALS, AND SHOWCASES
        • Table PRODUCT LAUNCHES, APPROVALS, AND SHOWCASES, 2013-2016
      • AGREEMENTS AND PARTNERSHIPS
        • Table AGREEMENTS AND PARTNERSHIPS, 2013-2016
      • ACQUISITIONS
        • Table ACQUISITIONS, 2013-2016
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS, 2013-2016
  • COMPANY PROFILES
    • INTRODUCTION
    • ROCHE DIAGNOSTICS LIMITED (A SUBSIDIARY OF F. HOFFMAN-LA ROCHE LTD.)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SIEMENS AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIOMÉRIEUX SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ALERE INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • LSI MEDIENCE CORPORATION (A SUBSIDIARY 0F MITSUBISHI CHEMICAL HOLDINGS CORPORATION)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ORTHO CLINICAL DIAGNOSTICS (A SUBSIDIARY OF THE CARLYLE GROUP)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • RANDOX LABORATORIES LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • GUANGZHOU WONDFO BIOTECH CO., LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report